Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDGF-BB in Advanced Peri-implantitis-related Bone Defect
NCT06390124Phase 4Completed
- Sponsor
- CICOM Badajoz
- Start
- Sep 2022
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of platelet-derived growth factor in peri-implantitis, sponsored by CICOM Badajoz. Started Sep 2022; status: completed.
02
Drugs
platelet-derived growth factor
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT06390124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06390124.